Cognizant Technology Solutions Corp vs Herbalife Nutrition Ltd — how do they compare? Cognizant Technology Solutions Corp trades at $59.2 (market cap $27.03B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: Cognizant Technology Solutions Corp is far larger — about 20.2× Herbalife Nutrition Ltd's market cap, and Cognizant Technology Solutions Corp pays a 2.2% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cognizant Technology Solutions Corp for 57 Days and Herbalife Nutrition Ltd for 43 Days on average.
| CTSH | HLF | |
|---|---|---|
Market Cap | $27.03B | $1.34B |
Volume | 9,883,888 | 1,589,457 |
Sector | Technology | Consumer Staples |
52-Week High | $86.70 | $19.96 |
52-Week Low | $38.73 | $7.75 |
Typical Hold Time | 57 Days | 43 Days |
Enterprise Value | $28.08B | $3.18B |
Dividend Yield | 2.2% | — |
Signals from Pluang's Aura AI — not financial advice
Cognizant Technology Solutions (CTSH) trades at $60.01, up 5.15% over 24 hours, reflecting strong momentum near its pivot point of $58. The stock shows bullish technical signals with moving averages supporting an uptrend. Fundamentally, CTSH maintains solid profitability with a 10.26% net margin and a modest P/E of 12.88. Recent earnings beats in Q4 2025 and Q1 2026 were offset by a Q2 2026 miss, with Q3 2026 results pending. Positive news includes AI-driven partnerships and employer awards, enhancing its growth narrative.
CTSH presents a balanced investment case with a consensus price target of $64.25 offering ~7% upside. Strengths include stable cash flow and undervaluation relative to peers, but risks involve IT spending pressures from AI disruption and competitive threats. Analyst sentiment is evenly split between Buy and Hold, indicating cautious optimism. The stock's outlook hinges on execution in AI services and sustaining margin discipline amid industry headwinds.
HLF trades at $12.82, up 1.34% today, with a bullish technical signal from moving averages and oscillators. The company reported mixed quarterly earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026. Revenue has been stable around $5.0B annually, with a net income margin of 4.53% in 2025. Recent news includes a $250 million share repurchase program and a planned CEO transition effective October 31, 2026.
The stock appears undervalued with a P/E of 8.22 and P/S of 0.26, supported by a 53.84% analyst buy rating and a $19.00 consensus price target. Key risks include high debt levels, with total liabilities at $3.53B, and inconsistent earnings performance. Positive cash flow trends in 2026 projections and margin expansion plans offer potential upside, but investor caution is warranted due to ongoing leadership changes and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →